Synaptogenix Inc (SNPX)

[InTheTrenches]

If the results show no difference between Bryostatin and placebo, I think we wake up Monday morning to a sub-$1 stock. Realistically, if Bryostatin fails NTRP has nothing else to offer.

If there's no difference, probably sub-$5. There's $3 in cash/share. Also, if Bryostatin just misses statistically significant results, there will be new AD trials, a Rhett's trial, etc., so we might not drop below $10/share.

It's very important to remember that although NTRP currently has a small public float of just a few million shares, the company has shareholder approval to issue 150 million more. If we then do a back of envelope calculation and grant NTRP a $15 billion market cap with a float of 155 million shares, we get a price per share of $100. Again, that's if the company issues all the approved shares - not a given.

If positive results, you think Neurotrope will sell all the remaining authorized 135 million shares at $100/share? I don't think I've ever seen a development stage company raise $13B. What would we use all that cash for?

More likely that we sell 1M shares at $100/share to raise $100M (that's the max available in the shelf we just filed). Fully diluted, that brings us to 15M shares, so under your scenario ($15B market cap), we would be trading at $1000/share.

I certainly understand skepticism, as no company has ever found a cure for Alzheimers. However, human history is filled with stories of impossible things that had never been done, and then someone did them. Perhaps this week will reveal yet another. I hope so... not just for my wallet - but because my father has dementia and I would dearly love to get something into his brain to stop his decline. That would mean more to me than any profits that might be coming our way. Good luck to all and God Bless Dr. Alkon.

I hope so, too...good luck.